Evelo Therapeutics developing microbiome based cancer therapies
Evelo Therapeutics is a new company focused on leveraging the power of the microbiome to develop novel therapies for cancer. It has with an initial capital commitment of $35 million. Evelo is pioneering Oncobiotic™ therapeutics, a new modality in cancer therapy based on the cancer microbiome. Evelo is the first company to systematically identify, characterize …